ISTALOL (timolol maleate ophthalmic solution) ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

ISTALOL (timolol maleate ophthalmic solution) ophthalmic solution is available in a concentration of 0. 5 percent. The starting dose is one drop of 0. 5 percent ISTALOL (timolol maleate ophthalmic solution) in the affected eye(s) once a day in the AM. If the patient's intraocular pressure is not at a satisfactory level on this regimen, concomitant therapy with other agent(s) for lowering intraocular pressure can be instituted.

The concomitant use of two topical beta-adrenergic blocking agents is not recommended. (See PRECAUTIONS: DRUG INTERACTIONS, Beta-adrenergic blocking agents.)

Sterile Ophthalmic Solution ISTALOL (timolol maleate ophthalmic solution) is a clear, colorless to light yellow solution. ISTALOL (timolol maleate ophthalmic solution) Ophthalmic Solution, 0.5% supplied in white LDPE bottle with 15 mm LDPE yellow cap and 15 mm LDPE white dropper tip as follows:

NDC 67425-003-50 5 mL in 10 mL container
NDC 67425-003-12 2.5 mL in 7.5 mL container

Storage

Store at 15-25°C (59-77°F)

Manufactured for: SENJU Pharmaceutical Co., Ltd., Osaka, Japan 541-0046. By: Bausch & Lomb Incorporated Tampa, FL 33637. Distributed by: ISTA Pharmaceuticals®, Inc., Irvine, CA 92618. Issued December 2005.

Last reviewed on RxList: 3/27/2009
This monograph has been modified to include the generic and brand name in many instances.